Due to the actions of a 3rd party, our laboratory software is unable to process orders at our normal capacity. This is not a data breach. If this affects your laboratory orders, we will contact you directly. You do not need to call the practice.

About Us

NYOH plays role in new drug test to detect cancer

9/09/2020

Amy Zuchelkowski, Director of Research Operations, talks with WNYT's Benita Zahn about a new clinical trial that tests for 50 cancers. NYOH participated in a trial that was a precursor to Pathfinder, with Dr. Lawrence Garbo as Principal Investigator. 

NYOH offers the region's largest clinical research operation, participating in more than 500 drug trials over the past 40 years -- leading to 50 new FDA-approved cancer treatments. Search open trials by cancer type or learn more about the advantages of participating in a clinical trial.